Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2014 1
2016 1
2017 2
2018 1
2019 3
2020 2
2021 1
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
[Cancer care for women in Germany - what is new since 2020?].
Kunstein A, Fürst S, Röbl-Mathieu M, Mahner S. Kunstein A, et al. Among authors: furst s. MMW Fortschr Med. 2022 Sep;164(16):42-45. doi: 10.1007/s15006-022-1822-y. MMW Fortschr Med. 2022. PMID: 36123484 Review. German. No abstract available.
Prostaglandin E2 receptor EP1 expression in vulvar cancer.
Buchholz A, Vattai A, Fürst S, Vilsmaier T, Zati Zehni A, Steger A, Kuhn C, Schmoeckel E, Dannecker C, Mahner S, Jeschke U, Heidegger HH. Buchholz A, et al. Among authors: furst s. J Cancer Res Clin Oncol. 2023 Jul;149(8):5369-5376. doi: 10.1007/s00432-022-04487-z. Epub 2022 Nov 27. J Cancer Res Clin Oncol. 2023. PMID: 36436093 Free PMC article.
MTA1 as negative prognostic marker in vulvar carcinoma.
Wanka G, Jueckstock J, Wild CM, Vattai A, Fürst S, Heidegger HH, Kuhn C, Schmoeckel E, Jeschke U, Dannecker C. Wanka G, et al. Among authors: furst s. J Cancer Res Clin Oncol. 2023 Aug;149(9):6191-6201. doi: 10.1007/s00432-023-04579-4. Epub 2023 Jan 23. J Cancer Res Clin Oncol. 2023. PMID: 36689059 Free PMC article.
T-Cell Density at the Invasive Margin and Immune Phenotypes Predict Outcome in Vulvar Squamous Cell Cancer.
Burandt E, Blessin NC, Rolschewski AC, Lutz F, Mandelkow T, Yang C, Bady E, Reiswich V, Simon R, Sauter G, Mahner S, Gregorio N, Klapdor R, Kalder M, Braicu EI, Fürst S, Klar M, Strauß HG, Prieske K, Wölber L. Burandt E, et al. Among authors: furst s. Cancers (Basel). 2022 Aug 31;14(17):4246. doi: 10.3390/cancers14174246. Cancers (Basel). 2022. PMID: 36077784 Free PMC article.
EP4 as a Negative Prognostic Factor in Patients with Vulvar Cancer.
Buchholz A, Vattai A, Fürst S, Vilsmaier T, Kuhn C, Schmoeckel E, Mayr D, Dannecker C, Mahner S, Jeschke U, Heidegger HH. Buchholz A, et al. Among authors: furst s. Cancers (Basel). 2021 Mar 19;13(6):1410. doi: 10.3390/cancers13061410. Cancers (Basel). 2021. PMID: 33808776 Free PMC article.
Malnutrition and clinical outcome in gynecologic patients.
Hertlein L, Kirschenhofer A, Fürst S, Beer D, Göß C, Lenhard M, Friese K, Burges A, Rittler P. Hertlein L, et al. Among authors: furst s. Eur J Obstet Gynecol Reprod Biol. 2014 Mar;174:137-40. doi: 10.1016/j.ejogrb.2013.12.028. Epub 2014 Jan 14. Eur J Obstet Gynecol Reprod Biol. 2014. PMID: 24485666
Association between obesity and vulvar cancer recurrence: an analysis of the AGO-CaRE-1 study.
Klapdor R, Hillemanns P, Wölber L, Jückstock J, Hilpert F, de Gregorio N, Hasenburg A, Sehouli J, Fürst S, Strauss H, Baumann K, Thiel F, Mustea A, Meier W, Harter P, Wimberger P, Hanker L, Schmalfeld B, Mahner S. Klapdor R, et al. Among authors: furst s. Int J Gynecol Cancer. 2020 Jul;30(7):920-926. doi: 10.1136/ijgc-2019-001187. Epub 2020 May 28. Int J Gynecol Cancer. 2020. PMID: 32467335
Cytoplasmic VDR expression as an independent risk factor for ovarian cancer.
Czogalla B, Deuster E, Liao Y, Mayr D, Schmoeckel E, Sattler C, Kolben T, Hester A, Fürst S, Burges A, Mahner S, Jeschke U, Trillsch F. Czogalla B, et al. Among authors: furst s. Histochem Cell Biol. 2020 Oct;154(4):421-429. doi: 10.1007/s00418-020-01894-6. Epub 2020 Jun 22. Histochem Cell Biol. 2020. PMID: 32572587 Free PMC article.
Predicting the course of disease in recurrent vulvar cancer - A subset analysis of the AGO-CaRE-1 study.
Woelber L, Eulenburg C, Kosse J, Neuser P, Heiss C, Hantschmann P, Mallmann P, Tanner B, Pfisterer J, Jückstock J, Hilpert F, de Gregorio N, Iborra S, Sehouli J, Ignatov A, Hillemanns P, Fürst S, Strauss HG, Mahner S, Prieske K; AGO-CaRE 1 investigators. Woelber L, et al. Among authors: furst s. Gynecol Oncol. 2019 Sep;154(3):571-576. doi: 10.1016/j.ygyno.2019.07.009. Epub 2019 Jul 17. Gynecol Oncol. 2019. PMID: 31324454
16 results